Best Pharma Strategies from the Experts

The challenges healthcare executives and administrators face are constantly changing. Host Kevin Stevenson talks with the heroes behind the heroes that are enabling hospitals, urgent care centers and telemedicine operators to spend their time tending to patients, while they handle the logistics.

 

At one point in his career, I Don’t Care Host Kevin Stevenson spent some time on the pharma side of things, in between working at hospitals.

Today he dives back into that world with Donovan Quill, President, and CEO at Optime Care, a nationally recognized pharmacy, distribution, and patient management organization that creates the trusted path to a fulfilled life for patients with rare and orphan disorders.

“What we try to do is create a holistic program for those patients where we combine all the services you would see in a pharmacy in a patient care model,” Quill said. “We try to create a one-stop-shop for patients to really get the care they need from a support standpoint, from affordability, and also to distribute their products to them in their home or site of care.”

“Our patient populations we treat here at Optime care range from 16 patients nationwide all the way up to a couple of thousand.” – Donovan Quill

Orphan disorders and drugs are a bit different from regular pharmaceuticals. Typically, an orphan drug is a treatment for a condition with less than 200,000 patients in the U.S., according to the FDA definition. But, what they do at Optime Care is treat disorders that are even more rare, or “Ultra orphan,” according to Quill.

“Our patient populations we treat here at Optime care range from 16 patients nationwide all the way up to a couple of thousand,” Quill said. “We really try to focus on the patients who need a little extra care.”

Most of the time, the patients they treat have a disorder they’ve never heard of and are treated with a product they can’t pronounce, Quill said jokingly.

Listen to Previous Episodes of I Don’t Care!

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

spiral growth
Spiral Growth: The Career Strategy That Builds Real Leaders
February 11, 2026

Leadership pipelines are under pressure. Companies are moving faster, roles are becoming more cross-functional, and high-potential talent is expected to deliver beyond narrow job descriptions earlier in their careers. At the same time, the World Economic Forum estimates that 39% of workers’ core skills will need to evolve by 2030 to keep pace with…

Read More
ethical AI
In the Race to Build Smarter AI, Technology Leaders Shouldn’t Forget That Innovation Needs Oversight
February 11, 2026

When a résumé is filtered out, a loan is denied, or a piece of content never reaches its audience, artificial intelligence may be the unseen hand behind the outcome. As these systems spread across the tools and institutions that shape daily life, the assumptions and priorities of their designers are carried forward into decisions…

Read More
Resource Officers
Beyond Enforcement: The Evolving Role of School Resource Officers
February 10, 2026

School Safety Today podcast, presented by Raptor Technologies. In this episode of School Safety Today, host Dr. Amy Grosso sits down with Dr. Penny Schultz, Assistant Director of School Safety and Security at Chesapeake Public Schools, to unpack the often-misunderstood role of School Resource Officers (SROs). The conversation highlights how effective SROs function not…

Read More
transportation management
Transportation Management Systems Don’t Compete With Carriers, Brokers, or Shippers — They Align Them
February 10, 2026

Transportation management systems are undergoing a quiet but consequential shift. Once viewed primarily as tools for tracking loads and storing paperwork, modern TMS platforms are increasingly expected to function as the operational backbone of logistics organizations. As freight volumes continue to fluctuate, margins remain tight, and supply chains rely on a growing mix of…

Read More